Related Experiment Video
Updated: Feb 1, 2026

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
Published on: November 19, 2020
Pathological analyses of very long-term sirolimus-eluting stent implantation in human coronary artery
Masao Imai1, Takeshi Kimura1, Junichi Tazaki1
1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shougoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Insights
Autopsy of a sirolimus-eluting stent (SES) recipient revealed neoatherosclerosis, characterized by lipid accumulation around struts, despite minimal neointimal formation and no restenosis or thrombosis. Long-term follow-up is crucial after SES implantation.
Area of Science:
- Cardiovascular Pathology
- Interventional Cardiology
- Biomaterials Science
Background:
- Sirolimus-eluting stents (SES) are widely used for coronary artery disease.
- Long-term histopathological data after SES implantation are limited.
- Understanding late stent behavior is crucial for improving stent design.
Observation:
- A 73-year-old male patient with coronary artery disease received SES in the LAD and LCX.
- The patient died after 57 months due to unrelated causes.
- Autopsy provided a unique opportunity for very-late-stage stent analysis.
Findings:
- Histopathology showed mild neointimal formation with patent lumens and endothelial coverage in stented segments.
- Significant findings included necrotic core formation with cholesterol clefts around stent struts, indicative of neoatherosclerosis.
- No evidence of restenosis, neointimal rupture, or stent thrombosis was observed.
Implications:
- Neoatherosclerosis, a late complication, can occur even with favorable short-term stent healing.
- The findings highlight the need for further development of biocompatible drug-eluting stents to minimize arterial wall inflammation.
- Close clinical monitoring is recommended for patients with long-term SES implantation.
Abstract:
A 73-year-old man underwent sirolimus-eluting stent (SES) implantation for chest pain on exertion with left anterior descending coronary artery (LAD) and left circumflex coronary artery (LCX). The patient died due to non-obstructive mesenteric ischemia after 57 months of SES implantation. An autopsy demonstrated that the lesions of stented site at LAD and LCX were histopathologicaly similar images. In short, only mild neointimal formation with enough patent lumen was observed in all stented sites with no evidence of restenosis. In addition, complete coverage of endothelial cells in the surface of neointima was visible. Furthermore, necrotic core formation with a lot of circumferential cholesterol clefts was evident around the struts. In spite of these findings, observations of neointimal rupture and stent thrombosis were not found in this very late period autopsy study. In this histopathological examination, although neointimal coverage with enough lumen was observed, accumulation of extracellular lipid and cholesterol crystal was shaping necrotizing core, in short neoatherosclerosis. In the future, biocompatible drug-eluting stents which do not induce inflammation to the arterial wall post stenting should be appropriately addressed by the future development of improved coronary stents. <Learning objective: This manuscript contains original materials from pathological analysis of very long-term SES implantation. The current case report is the first one with very long-term course after SES implantation over 4 years and 9 months. In this pathological examination, although neointimal coverage with enough lumen was observed, neoatherosclerotic change around stent struts was evident. We should observe close clinical follow up after SES implantation.>.
More Related Videos
04:30A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
High-Performance Liquid Chromatography: Elution Process